You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020156034
Dec 20203208
Jan 20212806
Feb 202148016
Mar 202174017
Apr 20214208
May 20211007
Jun 20210017
Jul 20210012
Aug 20210010
Sep 20210018
Oct 202152033
Nov 202165020
Dec 202172014
Jan 202240020
Feb 202256020
Mar 20227209
Apr 20226007
May 20223209
Jun 20223008
Jul 20223007
Aug 20223206
Sep 20222207
Oct 20222605
Nov 20223204
Dec 20224208
Jan 20231606
Feb 2023605
Mar 20232002
Apr 202316010
May 20231002
Jun 20233205
Jul 20231006
Aug 20231604
Sep 2023802
Oct 20233206
Nov 20231602
Dec 20236803
Jan 2024602
Feb 2024602
Mar 202414020
Apr 20241606
May 20241601
Jun 20242409
Jul 20242609
Aug 20241008
Sep 20242403
Oct 202422010
Nov 20242408
Total14910461